A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
1 other identifier
observational
30,000
1 country
4
Brief Summary
The purpose of this study is to provide messages to providers if their patient is at high risk of developing intraoperative hypotension based on past medical history and co-morbidities preoperatively and minutes of hypotension intraoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2018
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 28, 2018
CompletedFirst Submitted
Initial submission to the registry
August 8, 2019
CompletedFirst Posted
Study publicly available on registry
August 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2019
CompletedMarch 6, 2024
March 1, 2024
1 year
August 8, 2019
March 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acute Kidney Injury (AKI)
Risk adjusted rate of postoperative AKI
within 7 days post-surgery
Secondary Outcomes (1)
Hypotension
1) For each month from 12 months before pathway go-live until 12 months after go-live.
Study Arms (1)
Intervention Group
All patients scheduled for surgery at a UCLA site in the one year period after go-live
Interventions
Providers will be alerted if their patients are at high risk of hypotension or at increased risk of sequelae from hypotension. Intraoperatively, if patients have more than 10 minutes of hypotension an alert will be displayed on the screen.
Eligibility Criteria
All patients undergoing surgery at any of the UCLA operative locations
You may qualify if:
- \- All patients undergoing surgery at any of the UCLA operative locations
You may not qualify if:
- Patients less than age 18
- Patients undergoing cardiac surgery or liver transplantation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Jules Stein Eye Institute at UCLA
Los Angeles, California, 90095, United States
Ronald Reagan UCLA Medical Center
Los Angeles, California, 90095, United States
UCLA Ambulatory Surgery Center
Los Angeles, California, 90095, United States
UCLA Medical Center, Santa Monica
Santa Monica, California, 90404, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2019
First Posted
August 20, 2019
Study Start
September 28, 2018
Primary Completion
October 5, 2019
Study Completion
October 5, 2019
Last Updated
March 6, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share